marta sbaraglia

[Giacomo G Baldi @GiacomoGBaldi]

Prof. Dei Tos’ Herman Suite Lecture was truly inspiring.
The evolution of sarcoma classification is a shared journey! Progress only happens through real collaboration among clinicians, researchers, and pathologists! @apdeitos @ctosociety @ItaSarcomaGroup #ctos2025

[CTOS @ctosociety]

Thrilled to announce that the Herman Suit Lecture at #CTOS2025 will be delivered by 🎖️ Prof. Paolo Dei Tos, a global leader in sarcoma pathology
🌟His work reshaped how we classify and understand these rare tumors.
A well-deserved recognition!
#Sarcoma #Oncology @apdeitos

[Paolo Dei Tos @apdeitos]

The Padua University Pathology tribe shining in Baltimore at #USCAP2024.

[Celso Mello @CelsoMello15]

Great presentation about #sarcoma classification. @apdeitos @SelnetH2020 #CostaRica

[Paolo Dei Tos @apdeitos]

The meeting of the Italian Society of Pathology #Siapec-IAP Took off yesterday in Padua. 600 pathologists sharing expertise and ideas for 4 days.

[Italian Sarcoma Group @ItaSarcomaGroup]

The last journal of the year. This is about @ASCO and @AACR updates. Here Marta Sbaraglia great collaborator or @apdeitos is presenting new challenging entities (1/6)

[Paolo Dei Tos @apdeitos]

Diagnostic Histopathology of Bone and Soft Tissue Tumors. Sarcoma fans may enjoy this educational event to be held in Padua on 5th and 6th May 2022. Hope to see you https://t.co/LD1lz4B4oH

[Paolo Dei Tos @apdeitos]

I cannot believe that a civilized country such as Great Britain can allow Dr. @DoctorChristian to offend all Italians, all the patients who are suffering and dying, all the people who are trying to fight against the pandemia. Shame on you @DoctorChristian.

[Paolo Dei Tos @apdeitos]

ESMO Sarcoma & GIST meeting started in Milan. Passionate discussion on NTRK rearranged sarcomas is ongoing among top experts in the faculty closed meeting.

[marta sbaraglia @sbamarta]

Prof. Dei Tos presenting at #CTOS2019 in Tokyo an update on WHO classification of Soft Tissue Tumors.

[Oncoinfo @Oncoinfo_it]

@apdeitos on NTRK inhibitors #ASCO19 #precisionmedicine @giorgioscaglio3 @casali_pg @georgedemetrik @DanaFarber

[PharmaMar @PhrmMar]

Un adelanto de la ponencia del #oncólogo Paolo Dei Tos @apdeitos en el congreso internacional Soft Tissue Sarcoma: Evidence & Experience sobre el impacto de la #genética molecular en la evolución de la clasificación del esta enfermedad #STSMadrid19 #oncology #sarcoma

[Marco Fiore, MD, FACS, FEBSh @FioreDoc]

@apdeitos the pathologic diagnosis in #sarcoma is a global challenge, network and collaboration is needed to improve education @_rarecancer #ESMOAsia18

[marta sbaraglia @sbamarta]

Prof. Paolo Dei Tos introducing Sarcoma of the Year session at CTOS2018 in Rome.

[Paolo Dei Tos @apdeitos]

Registration to next May course on Oncologic Pathology is now open. Check program at: https://t.co/HDPzGzEDxe.

[Paolo Dei Tos @apdeitos]

CTOS2018: dear Sarcoma friends. Just to remind you that abstract submission is ongoing. Hope to see you in Rome next October.

[Paolo Dei Tos @apdeitos]

Great Sarcoma sessions at ESMO Asia 2017 in Singapore. David Thomas and Paolo Casali chairing Rare Cancer Synposium.

[Paolo Dei Tos @apdeitos]

Amazing international audience gathered in Treviso last week. Sarcoma course with C Fletcher, J Hornick, P Nielsen, P Dal Cin, P Dei Tos.

[INFO SARCOMES @Infosarcomes]

#ESMO2017 : @apdeitos says unresectable bone sarcomas is a challenge in a challenge which requires multidisciplinarity #sarcoma #surgery

[AC Milan @acmilan]

👋🏻 @bonucci_leo19 at #CasaMilan